In HCT-116 CRC cells, Cinobufagin inhibited cell survival, with a half-maximal inhibitory concentration below 50 ng/mL at 48 and 72 hours. In H1299 cells, Cinobufagin significantly increased ROS levels relative to control cells in the absence of NAC, and NAC pretreatment significantly blocked these effects. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Reduced survival of colorectal cancer cells
Cell-based study · HCT-116 CRC cells [1]
CBG's IC50, the concentration that inhibited 50% of HCT-116 cell survival, was less than 50 ng/mL at 48 and 72 hours.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1-250 ng/mL
- Exposure duration
- 48 and 72 hours
- Reported limits
- Not stated in the sentences used: route, vehicle.
Methods and source locations
Compound reported in the paper: Cinobufagin
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
RESULTS > Cinobufagin (CBG) exerts potent cytotoxic and anti-proliferative activity against human CRC cells (S1, S2, S3); MATERIALS AND METHODS > Methyl thiazol tetrazolium (MTT) assay (S79); Figure 1 legend (S112)
MTT cell viability assay: MTT cell viability assay; comparator: untreated control group — RESULTS > Cinobufagin (CBG) exerts potent cytotoxic and anti-proliferative activity against human CRC cells (S2, S3)
Increased reactive oxygen species in lung cancer cells
Cell-based study · H1299 cells [2]
Levels of ROS in the H1299 cells treated with 1 and 2μM CB were significantly increased from 6.05% to 17.90% and 29.66%, as compared to the control cells. These effects were significantly blocked when the cells were pretreated with 5 mM NAC.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0, 1, 2 μM
- Exposure duration
- 24 hours of treatment
- Vehicle
- Dimethyl Sulfoxide (DMSO)
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: Cinobufagin
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
RESULTS > Treatments of CB leads to the generation of reactive oxygen species (ROS) and disruption of the mitochondrial transmembrane potential (MMP) through an intrinsic mitochondrial apoptosis pathway in human NSCLC cell lines (S34, S35); MATERIALS AND METHODS > Cell lines, antibodies, and reagents (S59); MATERIALS AND METHODS > Determination of ROS and MMP (S99, S100, S103)
The generation of ROS was then analyzed by flow cytometry.: The generation of ROS was then analyzed by flow cytometry.; comparator: control cells — RESULTS > Treatments of CB leads to the generation of reactive oxygen species (ROS) and disruption of the mitochondrial transmembrane potential (MMP) through an intrinsic mitochondrial apoptosis pathway in human NSCLC cell lines (S34, S35); MATERIALS AND METHODS > Determination of ROS and MMP (S99, S103)